Literature DB >> 9121683

Glutamate stimulates neurogranin phosphorylation in cultured rat hippocampal neurons.

P Rodríguez-Sánchez1, P Tejero-Díez, F J Díez-Guerra.   

Abstract

Neurogranin is a calmodulin-binding and a protein kinase C substrate, that is expressed in telencephalic regions of the rat brain and has been associated with signal transduction and long-term potentiation (LTP). We here report that neurogranin is present in cultured hippocampal neurones, although in amounts lower than those present in the adult hippocampus, and that is also phosphorylated 'in vivo'. Glutamate receptor activation rapidly and significantly increases neurogranin phosphorylation, which achieves maximal phosphate labeling after ionotropic receptor stimulation (kainate and N-methyl-D-aspartate) and more moderate one after metabotropic receptor activation. It is proposed that neurogranin phosphorylation responds to changes in intracellular free Ca2+ and, also, that an increase in neurogranin phosphorylation contributes to enhance and extend calmodulin action, and therefore participate in post-synaptic signal transduction and LTP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121683     DOI: 10.1016/s0304-3940(96)13309-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  RC3/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes.

Authors:  D D Gerendasy; J G Sutcliffe
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

2.  Neurogranin binds to phosphatidic acid and associates to cellular membranes.

Authors:  Irene Domínguez-González; Silvia N Vázquez-Cuesta; Alicia Algaba; F Javier Díez-Guerra
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

Review 3.  Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia.

Authors:  Yael Chertkow; Orly Weinreb; Moussa B H Youdim; Henry Silver
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.